Although Valsartan products can cause serious problems, you do not have to sue the makers of these drugs alone. You can opt to represent yourself without the help of a lawyer, but this could lead to a low settlement. Drug makers often spend a lot of money on lawyers, so going up against them can be intimidating. You can maximize your chances of getting the full compensation you deserve by hiring an experienced Valsartan Lawyer.

1,072 plaintiffs in multidistrict litigation

A lawsuit filed in the U.S. against a generic drug maker, Valsartan, alleges that the product contained NDMA, a probable human carcinogen, during production. The active pharmaceutical ingredient of the drug is manufactured by different companies, including Hetero Labs and Zhejiang Huahai Pharmaceutical Co. Ltd. in China. Plaintiffs allege that NDMA was added to the drug during the manufacturing process and that this contamination caused serious side effects.

The number of lawsuits against Valsartan has climbed above 1,000. A federal panel recently consolidated ten valsartan lawsuits into one and identified at least 30 more related suits. The lawsuits name twenty valsartan manufacturers and companies. As of July, 88 lawsuits were still pending. Neither a settlement nor a trial date has been set for any of the lawsuits.

200th case filed in class action suit

The two hundredth case has been filed in a class action suit against the makers of valsartan cancer drugs. This case centers on the contamination of valsartan, and plaintiffs allege that the drug caused their cancers. Meanwhile, insurance companies allege that valsartan recalls increased the cost of the drug. If that is true, the insurance companies could be on the hook for billions of dollars.

Despite the widespread use of the drug, the pharmaceutical industry has failed to disclose the potential dangers of the medication. The majority of valsartan sold in the United States and around the world has significant amounts of carcinogenic impurities. This is even though Teva has marketed the drug to millions of consumers, despite its alleged risks.

NDMA contamination was discovered by a private pharmacy

The recent multidistrict litigation involving Valsartan and NDMA contamination was the result of the worldwide recall of the angiotensin II receptor blockers. These drugs have been contaminated with cancer-causing nitrosamines and NDMA. A private pharmacy had discovered the contamination, and it was the result of improper manufacturing processes. The FDA failed to test the drugs, which could have prevented contamination and protected the public’s health. A GAO investigation showed that the FDA has serious gaps in its foreign drug oversight.

The FDA is investigating the NDMA contamination, which was first found in Zantac (ranitidine). The drug contains NDMA, which is considered intrinsic to the drug. Since then, a separate MDL was created for the federal cases. The multidistrict litigation over contaminated Valsartan is expected to pass 200 cases by the early 2020s.

Potential class-action lawsuits filed against generic valsartan makers

If you or a loved one has developed a serious medical condition after taking a generic version of valsartan, you may be entitled to file a lawsuit against the manufacturer. The FDA is investigating the drug, which is made by a drugmaker. Valsartan is a blood pressure medication. However, the company’s analysis revealed that it contains carcinogens. Because of the heightened risks associated with this medication, lawsuits have increased dramatically in recent years.

Numerous suits have been filed against Zhejiang Huahai Pharmaceutical, Solco Healthcare, Huahai, and Camber Pharmaceuticals. While the lawsuits are not guaranteed to win, they are likely to grow in number. The company is accused of failing to follow FDA warnings on manufacturing practices. The company is facing several multidistrict lawsuits over the product.

Leave a Reply

Your email address will not be published. Required fields are marked *